Alison N. Gencarelli

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

Tarun Kewalramani, Andrew D. Zelenetz, Stephen D. Nimer et al. · Blood · 2004 · 406 citations · Full text

Medicine, Immunology, Pharmacotherapy +12

Pentostatin, Cyclophosphamide, and Rituximab Is an Active, Well-Tolerated Regimen for Patients With Previously Treated Chronic Lymphocytic Leukemia

Nicole Lamanna, Matt Kalaycio, P. Maslak et al. · Journal of Clinical Oncology · 2006 · 150 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: Molecular Remissions Predict for Durable Complete Responses

Nicole Lamanna, Joseph G. Jurcic, Ariela Noy et al. · Journal of Clinical Oncology · 2008 · 66 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma

Craig H. Moskowitz, Paul A. Hamlin, Janice Gabrilove et al. · Annals of Oncology · 2007 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Treatment of chronic neutropenia associated with large granular lymphocytosis with cyclosporine a and filgrastim

Ann A. Jakubowski, Elliott F. Winton, Alison N. Gencarelli et al. · American Journal of Hematology · 1995 · 13 citations

Life Sciences, Hematology, Immunology +14